Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: XenaLives who wrote (6970)	8/24/2002 9:41:49 AM
From: Icebrg	Read Replies (2) \| Respond to of 52153

>>Can you give me a list of companies priced under $25/shr that have relatively unique niche in the sector and should be close to profitability in the next five years?>> Some suggestions. All speculative of course with the exception of the last one: NBIX, ICOS (@27 USD), SEPR, ALXN, LGND, NTII I would take away IMGN from your list. It is still too early to say if they will succeed with their platform. Ice Edit: Take out NBIX from the list. It is too "expensive". But it is a very interesting company with good science, management and a fair chance of becoming profitable. Unless someone munches it before time.

To: XenaLives who wrote (6970)	8/24/2002 9:42:43 AM
From: XenaLives	Respond to of 52153

Too late to edit, but I have set up a "Target Technologies" portfolio and attached it to the biotech TA thread. Subject 50740

To: XenaLives who wrote (6970)	8/24/2002 2:35:34 PM
From: nigel bates	Respond to of 52153

priced under $25/shr that have relatively unique niche in the sector and should be close to profitability in the next five years? CATG. I sincerely hope :-) (edit) I wouldn't put too much trust in IMGN. There are similar potential 'platforms' out there.